MARIJUANA & CANCER - WHAT OBAMA DOESN'T WANT YOU TO KNOW - Interviews w/Jack Herer & Rick Simpson

   

LogosMedia

 

Published on Aug 14, 2009

Anti-Cancer Properties of THC -- Research in Print:
[1] Parolaro and Massi. 2008. Cannabinoids as a potential new drug therapy for the treatment of gliomas. Expert Reviews of Neurotherapeutics 8: 37-49
[2] Guzman et al. 2006. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. British Journal of Cancer.
[3] Galanti et al. 2007. Delta9-Tetrahydrocannabinol inhibits cell cycle progression in human glioblastoma multiforme cells. Acta Oncologica 12: 1-9.
[4] Calatozzolo et al. 2007. Expression of cannabinoid receptors and neurotrophins in human gliomas. Neurological Sciences 28: 304-310.
[5] Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells. Journal of Neurooncology. 2005
http://www.ncbi.nlm.nih.gov/pubmed/16078104?dopt=Citation
[6] Cannabinoids and cancer. Mini-Reviews in Medicinal Chemistry. 2005
http://www.ingentaconnect.com/content/ben/mrmc/2005/00000005/00000010/art00006
[7] The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells. Gut. 2005 http://gut.bmj.com/cgi/content/abstract/54/12/1741
[8] Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Research. 2005 http://cancerres.aacrjournals.org/cgi/content/abstract/65/5/1635
[9] Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. Journal of Pharmacology And Experimental Therapeutics. 2004
http://jpet.aspetjournals.org/cgi/content/abstract/jpet.103.061002v1
[10] Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Research. 2004 http://cancerres.aacrjournals.org/cgi/content/full/64/16/5617
[11] Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro. BMJ Medicine. 2004
http://www.biomedcentral.com/1741-7015/2/34/abstract
[12] Cannabinoids: potential anticancer agents. Nature Reviews Cancer. 2003
http://americanmarijuana.org/Guzman-Cancer.pdf
[13] Inhibition of tumor angiogenesis by cannabinoids. The FASEB Journal. 2003
http://www.fasebj.org/cgi/content/full/17/3/529
[14] Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. Journal of Clinical Investigation. 2003
http://www.jci.org/articles/view/16116/version/1
[15] Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nature Medicine. 2000
http://www.annieappleseedproject.org/anacofcanrat.html
[16] Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Letters. 1998 http://www.febsletters.org/article/PIIS0014579398010850/abstract
[17] The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proceedings of the National Academy of Sciences of the USA. 1998
[18] Toxicology and Carcinogenesis Studies of 1 trans-delta-9-tetrahydrocannabinol in F344N/N Rats and BC63F1 Mice. National Institutes of Health National Toxicology Program, NIH Publication No. 97-3362. 1996.
[19] Antineoplastic activity of cannabinoids. Journal of the National Cancer Institute. 1975 http://www.ukcia.org/research/AntineoplasticActivityOfCannabinoids/default.html

Recent Research on Medical Marijuana
http://norml.org/index.cfm?Group_ID=7002

Delta9-Tetrahydrocannabinol-Induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria
http://mcr.aacrjournals.org/cgi/content/abstract/4/8/549

Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
http://www.nature.com/nm/journal/v6/n3/fig_tab/nm0300_313_F1.html

Order The Emperor Wears No Clothes: http://astore.amazon.com/gnosmedi-20/detail/1878125028